cardiology
Grogan Staging System for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Alternative three-stage clinical staging for ATTR-CM using NT-proBNP and troponin T. Complements the Gillmore staging system; validated in the Mayo Clinic ATTR-CM cohort.
References
- Grogan M et al. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart Fail Clin. 2017;13(4):509-524.
- Maurer MS et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007-1016.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.